Abstract
The effects of heat on intracellular accumulation of anthracyclines were investigated by laser flow cytometry analysis. Sarcoma-180 cells were exposed to Adriamycin (ADM), epirubicin (EPIR), daunomycin (DM), THP-Adriamycin (THP), ME-2303 (ME) and KRN-8602 (KRN) at 37°C and at higher temperatures. There was a dose-dependent increase in the fluorescence intensity of all drugs at 37°C, but heat varied the fluorescence intensity of each drug. At 43°C the cellular fluorescence of ADM and EPIR increased by approximately 200%, but for DM the increase was 110–130%. The cellular fluorescence of THP and ME was little affected by heat, and heat reduced that of KRN to 80–90%. Each drug showed was unique in the relationship between drug exposure time and the fluorescence intensity at 37°C and 43°C. Cytotoxicity determined by the MTT assay was enhanced with heat in the cases of ADM and EPIR, but not with DM, THP, ME, or KRN. Thus, ADM and EPIR are expected to show enhanced antitumor activities when given in combination with hyperthermia.
Similar content being viewed by others
References
Bachur NR, Gordon S, Gee MV (1978) A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res 38: 1745
Carmichael J, Degraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay. Assessment of chemosensitivity testing. Cancer Res 47: 936
Cole SPC (1986) Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol 17: 259
Dahl O (1983) Hyperthermic potentiation of doxorubicin and 4′-epi-doxorubicin in a transplantable neurogenic rat tumor (BT4A) in BD IX rats Int J Radiat Oncol Biol Phys 9: 203
Durand RE, Olive PL (1981) Flow cytometry studies of intracellular adriamycin in single cells in vitro. Cancer Res 41: 3489
Egorin MJ, Clawson RE, Ross LA, Bachur NR (1974) Cytofluorescence localization of Adriamycin and daunorubicin. Cancer Res 34: 2243
Frezard F, Garnier-Suillerot A (1991) DNA-containing liposomes as a model of the study of cell membrane permeation by anthracycline derivatives. Biochemistry 30: 5038
Hahn GM, Strande DP (1976) Cytotoxic effects of hyperthermia and Adriamycin on Chinese hamster cells. J Natl Cancer Inst 57: 1063
Hahn GM, Braun J, Har-Kedar I (1975) Thermochemotherapy: synergism between hyperthermia (42–43°) and Adriamycin (or bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci USA 72: 937
Inaba M, Johnson RK (1978) Uptake and retention of Adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia. Biochem Pharmacol 27: 2123
Krishan A, Ganapathi R (1979) Laser flow cytometry and cancer chemotherapy: Detection of intracellular anthracyclines by flow cytometry. J Histochem Cytochem 27: 1655
Krishan A, Ganapathi R (1980) Laser flow cytometric studies on the intracellular fluorescence of anthracyclines. Cancer Res 40: 3895
Krishan A, Sauerteig A, Gordon K, Swinkin C (1986) Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemia cells. Cancer Res 46: 1768
Kunimoto S, Miura K, Takahashi Y, Takeuchi T, Umezawa H (1983) Rapid uptake by cultured tumor cells and intracellular behavior of 4′-O-tetrahydropyranyladriamycin. J Antibiot (Tokyo) 36: 312
Lane P, Vichi P, Bain DL, Tritton TR (1987) Temperature dependence studies of adriamycin uptake and cytotoxicity. Cancer Res 47: 4038
Maehara Y, Anai H, Kusumoto H, Sugimachi K (1987) Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well-differentiated carcinoma. Eur J Surg Oncol 13: 203
Maehara Y, Anai H, Kusumoto H, Kusumoto T, Sugimachi K (1988) Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil. Dis Col Rect 31: 62
Nagaoka S, Kawasaki S, Sasaki K, Nakanishi T (1986) Intracellular uptake and retention and cytotoxic effect of adriamycin combined with hyperthermia in vitro. Jpn J Cancer Res 77: 205
Neidle S (1979) The molecular basis for the action of some DNA-binding drugs. Prog Med Chem 16: 151
Ohnoshi T, Ohnuma T, Beranek JT, Holland JF (1985) Combined cytotoxicity effect of hyperthermia and anthracycline antibiotics on human tumor cells. J Natl Cancer Inst 74: 275
Osborne EJ, Mackillop WJ (1987) The effect of exposure to elevated temperatures on membrane permeability to Adriamycin in Chinese hamster ovary cells in vitro. Cancer Lett 37: 213
Peterson C, Trouet A (1978) Transport and storage of daunorubicin and doxorubicin in cultured fibroblasts. Cancer Res 38: 4645
Rice GC, Hahn GM (1987) Modulation of Adriamycin transport by hyperthermia as measured by fluorescence-activated cell sorting. Cancer Chemother Pharmacol 20: 183
Saito A, Korenaga D, Maehara Y, Baba H, Okamura T, Sugimachi K (1992) In vitro succinate dehydrogenase chemosensitivity of gastric carcinoma — relationship to DNA content. Cancer Chemother Pharmacol 29: 185
Sakaguchi Y, Maehara Y, Emi Y, Kohnoe S, Sugimachi K (1993) Adriamycin combined with hyperthermia and dipyridamole is cytotoxic both in vitro and in vivo. Eur Surg Res (in press)
Tapiero H, Fourcade A, Vaigot P, Farhi JJ (1982) Comparative uptake of adriamycin an daunorubicin in sensitive and resistant Friend leukemia cells measured by flow cytometry. Cytometry 2: 298
Tarasiuk J, Garnier-Suillerot A (1992) Thermodynamics of the anthracycline-nuclei interactions in drug-resistant and drug-sensitive K562 cells. Biochem Pharmacol 43: 2575
Tarasiuk J, Frezard F, Garnier-Suillerot A, Gattegno L (1989) Anthracycline incorporation in human lymphocytes. Kinetics of uptake and nuclear concentration. Biochim Biophys Acta 1013: 109
Tewey KM, Rowe TC, Yand L, Halligan BD, Liu LF (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II, Science 226: 466
Tritton TR, Yee G (1982) The anticancer agent Adriamycin can be actively cytotoxic without entering cells. Science 217: 248
Tsuchiya T, Takagi Y, Umezawa S, Takeuchi T, Komoro K, Nosaka C, Umezawa H, Fukatsu S, Yoneta T (1988) Synthesis and antitumor activities of 14-O-acyl derivatives of 7-O-(2,6-dideoxy-2-fluoro-α-l-talopyranosyl)adriamycinone. J Antibiot (Tokyo) 41: 988
Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1982) 4′-O-Tetrahydropyranyladriamycin as a potential new anticancer agent. Cancer Res 42: 1462
Tsuruo T, Yusa K, Sudo Y, Takamori R, Sugimoto Y (1989) A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines. Cancer Res 49: 5537
Umezawa H, Nakajima S, Kawai H, Komeshima N, Yoshimoto H, Urata T, Odagawa A, Otsuki N, Tatsuya K, Ohtake N, Takeuchi T (1987) New morpholino anthracyclines, MX, MX2, and MY5. J Antibiot (Tokyo) 40: 1058
Watanabe M, Komeshima N, Nakajima S, Tsuruo T (1988) MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells. Cancer Res 48: 6653
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sakaguchi, Y., Maehara, Y., Inutsuka, S. et al. Laser flow cytometric studies on the intracellular accumulation of anthracyclines when combined with heat. Cancer Chemother. Pharmacol. 33, 371–377 (1994). https://doi.org/10.1007/BF00686265
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00686265